Not all p53 gain-of-function mutants are created equal

Cell Death and Differentiation

Volumn 20, Issue 7, 2013, Pages 855-857

  Mello, S S ^a   Attardi, L D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; PROTEIN P53;

CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL POPULATION; CELL SURVIVAL; DNA BINDING; DNA DAMAGE; GAIN OF FUNCTION MUTATION; GENOTYPE; HUMAN; MESENCHYMAL STEM CELL; MISSENSE MUTATION; NONHUMAN; NULL ALLELE; OLIGOMERIZATION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE; WILD TYPE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880309607     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.53     Document Type: Review

References (16)

1. Brady CA, Attardi LD. J Cell Sci 2010; 123: 2527-2532.
2. Beckerman R, Prives C. Cold Spring Harbor Perspect Biol 2010; 2: a000935.
3. Petitjean A et al. Hum Mut 2007; 28: 622-629.
4. Brosh R, Rotter V. Nat Rev Cancer 2009; 9: 701-713.
5. Dittmer D et al. Nat Genet 1993; 4: 42-46.
6. Shaulsky G, Goldfinger N, Rotter V. Cancer Res 1991; 51: 5232-5237.
7. Olive KP et al. Cell 2004; 119: 847-860.
8. Lang GA et al. Cell 2004; 119: 861-872.
9. Song H, Hollstein M, Xu Y. Nat Cell Biol 2007; 9: 573-580.
10. Liu DP, Song H, Xu Y. Oncogene 2009; 29: 949-956.
11. Hanel W et al. Cell Death Differ 2013; 20: 898-909.
12. Lu X, Liu DP, Xu Y. Oncogene 2012; e-pub ahead of print 23 July 2012; doi: 10.1038/onc.2012.299.
13. Li Y, Prives C. Oncogene 2007; 26: 2220-2225.
14. Xu J et al. Nat Chem Biol 2011; 7: 285-295.
15. Muller PAJ, Vousden KH. Nat Cell Biol 2013; 15: 2-8.
16. Bullock AN et al. Proc Natl Acad Sci 1997; 94: 14338-14342.